Skip to content

NYCHA Mindfulness-based Smoking Cessation Intervention

Feasibility and Accessibility of a Mindfulness-based Smoking Cessation Intervention for NYCHA Residents

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04334187
Enrollment
0
Registered
2020-04-06
Start date
2021-06-30
Completion date
2021-12-31
Last updated
2022-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco Use

Brief summary

The study will assess feasibility, accessibility and impact of a mindfulness-based smoking cessation group intervention for New York City Housing Authority (NYCHA) residents. Residents who smoke to receive an 8-week intervention. Participants will also be offered 4 weeks of nicotine replacement therapy (NRT).

Detailed description

The primary objective of this research is to examine the feasibility, accessibility and impact of a mindfulness-based smoking cessation program for NYCHA residents.

Interventions

BEHAVIORALMindfulness Based addition treatment

The intervention is comprised of 8 weekly group MBAT sessions. Two weekly groups of about 10 participants each will be conducted. All participants will also have the option to receive nicotine patches, gum, or lozenges for four weeks as part of their time in the study. Participants will complete surveys at enrollment (baseline), immediately after their last MBAT session (around 2 months after enrollment) and one month after completing treatment (3 months post-enrollment). Surveys will assess primary and secondary outcomes and satisfaction with the intervention.

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years * Current smoker (\>= 5 cigarettes per day). Dual tobacco users are eligible as long as their primary tobacco product is cigarettes. * Ready to quit smoking cigarettes within 30 days * Able to attend the 8 weekly MBAT sessions at the scheduled days/times * NYCHA resident * English language * Able to provide informed consent

Exclusion criteria

* Pregnant or breastfeeding * Patient Health Questionnaire-2 (PHQ-2) score indicating current risk for depression * Self-reported diagnosis of schizophrenia, bipolar disorder, schizotypal disorder or other psychotic disorder

Design outcomes

Primary

MeasureTime frameDescription
Number of participants who perceive the Mindfulness based addiction treatment as useful at time of EnrollmentBaselineParticipants will report their perceived usefulness and effectiveness of the intervention using self reported surveys at enrollment (baseline).
Number of participants who perceive the Mindfulness based addiction treatment as useful after last MBAT session.2 monthsNumber of participants will report their perceived usefulness and effectiveness of the intervention using self reported surveys after their last MBAT session (2 months after enrollment).
Number of participants who perceive the Mindfulness based addiction treatment as useful post treatment3 monthsParticipants will report their perceived usefulness and effectiveness of the intervention using self reported surveys one month after completing treatment (3 months post-enrollment).
Number of participants who perceive the Mindfulness based addiction treatment as effective3 monthsParticipants who self-report 7-day abstinence in the final follow up survey (3 months) will provide a biochemically validated saliva sample

Secondary

MeasureTime frameDescription
Number of participants who adhered to the Mindfulness based addiction treatment3 monthsThis will be reported in the number of sessions attended and completed mindfulness exercises in between the sessions.
Number of participants who self reported abstinence2 monthsThis will be self reported at the end of the treatment (2 months)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026